Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
45 Ergebnisse für "anti" unter Roche Glycart AG
Elecsys® Anti-HBe
... ilişkilendirilmektedir.2,3 HBeAg'nin anti-HBe'ye serokonversiyonu, aktif viral replikasyonun sona erdiğine işaret eder ve ... .3-6 Bu nedenle, Anti-HBe testinin kullanımı, HBV enfeksiyonunun seyrini ve kronik hepatit B ... Elecsys® Anti-HBe ... https://diagnostics.roche.com/tr/tr/products/params/elecsys- anti-hbe.html ... Elecsys® Anti-HBe ...
Elecsys® Anti-HBs II
... yol açtı.1 Anti-HBs, hepatit B yüzey antijenine yönelik bir antikordur.2,3 Anti-HBs, hepatit B yüzey ... antijeninin (HBsAg) ortadan kaybolmasından birkaç hafta sonra saptanabilir.4,5 Anti-HBs bir hepatit B ... Elecsys® Anti-HBs II ... https://diagnostics.roche.com/tr/tr/products/params/elecsys- anti-hbs-ii.html ... Elecsys® Anti-HBs II ...
Centenara Labs AG
8952 Schlieren, Wagistrasse 18
+41 44 730 12 90
info@centenara.com
Centenara Labs develops and invests in therapies that target geriatric diseases. Our goal is to expand healthspan, promoting overall health, well-being and longevity as the population ages. Centenara Labs supports pioneers in the field of aging to transform their scientific discoveries into medicines. We are building a product pipeline comprised of potential breakthrough therapeutics that treat diseases of aging and help reduce the growing strain on global healthcare systems as the world’s population ages.
Centenara Labs AG
Wagistrasse 18
8952 Schlieren
NovaGo Therapeutics AG
http://www.novagotherapeutics.com
8952 Schlieren, Wagistrasse 27
NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics that promote nerve repair and regeneration in the treatment of cerebral stroke and spinal cord injury. NovaGo is developing human antibody therapeutics against Nogo-A. Nogo-A is the most potent inhibitor of nerve fiber regeneration. Anti-NogoA treatment promotes recovery of function in several animal models of stroke. Novago Therapeutics' anti-NogoA treatment represents a novel, regenerative approach for stroke. Recovery of function in stroke and other neurological disorders will be a clinical breakthrough and have a major economic impact on health care.
NovaGo Therapeutics AG
Wagistrasse 27
8952 Schlieren
OMNIMEDICA Group AG
8952 Schlieren, Lättenstrasse 27
The company develops and distributes active ingredients and end products in the field of cosmeceuticals, nutritional supplements, sports, palliative medicine, dental medicine and detoxification/filter systems.
OMNIMEDICA Group AG
Lättenstrasse 27
8952 Schlieren
5 Ergebnisse für "anti" unter OMNIMEDICA Group AG
Kommentare zu: Produkty przeciwstarzeniowe
... Kommentare zu: Produkty przeciwstarzeniowe Kommentare zu: Produkty przeciwstarzeniowe Anti-Aging ... Kommentare zu: Produkty przeciwstarzeniowe Kommentare zu: Produkty przeciwstarzeniowe Anti-Aging ...
Omnimedycyna Archive | Omnimedica Group AG
... Omnimedycyna Archive | Omnimedica Group AG Omnimedycyna Archive | Omnimedica Group AG Anti-Aging ... Omnimedycyna Archive | Omnimedica Group AG Omnimedycyna Archive | Omnimedica Group AG Anti-Aging ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
3 Ergebnisse für "anti" unter University of Zurich
http://www.med.uzh.ch/dam/jcr:7300b5a8-5894-4895-96e1-fc62eef0c53b/Goetzpreis_Broschuere_2017.pdf, Georg Friedrich Götz-Preis 2017 Georg Friedrich Götz-Stiftung Medizinische Fakultät der Universit...
ssj-skt-inp.txt
... ! sat+sevya+pu.nya+padat-am upay- anti sadya.h ! y-am antar-a nanu mah-a+.rddhi+bh.rto* *api de/s-a ... * ! nis+toya+nadya* iva y- anti vig-itat-a.m* vai !!1005.21! yat+sevan-ad* gatim iha*-a/su ca y-a.m ... ! sat+sevya+pu.nya+padat-am upay- anti sadya.h ! y-am antar-a nanu mah-a+.rddhi+bh.rto* *api de/s-a ... * ! nis+toya+nadya* iva y- anti vig-itat-a.m* vai !!1005.21! yat+sevan-ad* gatim iha*-a/su ca y-a.m ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
3 Ergebnisse für "anti" unter Somagenetix
Dunkelfeldbefragung im Bereich "Jugend und Gewalt" - Machbarkeitsstudie
Dunkelfeldbefragung im Bereich "Jugend und Gewalt" - Machbarkeitsstudie, https://www.ius.uzh.ch/dam/jcr:00000000-5624-ccd2-ffff-ffff9dd8c25c/Manzoni_et_al_2012.pdf, Dunkelfeldbefragung im Bereich ...
IstitutoSvizzero
IstitutoSvizzero, https://www.sglp.uzh.ch/dam/jcr:ece2f32d-0bdc-403b-a9b6-35e6bb306c4b/ISR_RapportoAnnuale2010.pdf, IstitutoSvizzero JAHRESBERICHT RAPPORT ANNUEL RAPPORTO ANNUALE 2010 2010 3 Stift...